Literature DB >> 12871426

CD154 (CD40 ligand)-deficient mice exhibit prolonged bleeding time and decreased shear-induced platelet aggregates.

A R Crow, V Leytin, A F Starkey, M L Rand, A H Lazarus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12871426     DOI： 10.1046/j.1538-7836.2003.t01-1-00115.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  10 in total

Review 1.  Minding the gaps to promote thrombus growth and stability.

Authors:  Lawrence F Brass; Li Zhu; Timothy J Stalker
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

2.  Nondepleting anti-CD40-based therapy prolongs allograft survival in nonhuman primates.

Authors:  I R Badell; P W Thompson; A P Turner; M C Russell; J G Avila; J A Cano; J M Robertson; F V Leopardi; E A Strobert; N N Iwakoshi; K A Reimann; M L Ford; A D Kirk; C P Larsen
Journal:  Am J Transplant       Date:  2011-09-15       Impact factor: 8.086

3.  CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates.

Authors:  P Thompson; K Cardona; M Russell; I R Badell; V Shaffer; G Korbutt; G R Rayat; J Cano; M Song; W Jiang; E Strobert; R Rajotte; T Pearson; A D Kirk; C P Larsen
Journal:  Am J Transplant       Date:  2011-05       Impact factor: 8.086

Review 4.  Antibody-Targeted TNFRSF Activation for Cancer Immunotherapy: The Role of FcγRIIB Cross-Linking.

Authors:  Luyan Liu; Yi Wu; Kaiyan Ye; Meichun Cai; Guanglei Zhuang; Jieyi Wang
Journal:  Front Pharmacol       Date:  2022-07-05       Impact factor: 5.988

5.  Pharmacokinetics and pharmacodynamics of ASKP1240, a fully human anti-CD40 antibody, in normal and renal transplanted Cynomolgus monkeys.

Authors:  Anlun Ma; Hao Dun; Lijun Song; Yanxin Hu; Lin Zeng; Jieying Bai; Guangzhou Zhang; Fumitaka Kinugasa; Yasuhiro Miyao; Shozo Sakuma; Kazumichi Okimura; Noriyuki Kasai; Pierre Daloze; Huifang Chen
Journal:  Transplantation       Date:  2014-02-27       Impact factor: 4.939

6.  CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study.

Authors:  Anthony Shock; Linda Burkly; Ian Wakefield; Christopher Peters; Ellen Garber; Janine Ferrant; Frederick R Taylor; Lihe Su; Yen-Ming Hsu; David Hutto; Ali Amirkhosravi; Todd Meyer; John Francis; Sarah Malcolm; Martyn Robinson; Derek Brown; Stevan Shaw; Roland Foulkes; Alastair Lawson; Olivier Harari; Timothy Bourne; Alison Maloney; Neil Weir
Journal:  Arthritis Res Ther       Date:  2015-09-03       Impact factor: 5.156

7.  Characterization of ASKP1240, a fully human antibody targeting human CD40 with potent immunosuppressive effects.

Authors:  K Okimura; K Maeta; N Kobayashi; M Goto; N Kano; T Ishihara; T Ishikawa; H Tsumura; A Ueno; Y Miyao; S Sakuma; F Kinugasa; N Takahashi; T Miura
Journal:  Am J Transplant       Date:  2014-04-14       Impact factor: 8.086

8.  Effects of ASKP1240 combined with tacrolimus or mycophenolate mofetil on renal allograft survival in Cynomolgus monkeys.

Authors:  Lijun Song; Anlun Ma; Hao Dun; Yanxin Hu; Lin Zeng; Jieying Bai; Guangzhou Zhang; Fumitaka Kinugasa; Yuji Sudo; Yasuhiro Miyao; Kazumichi Okimura; Toru Miura; Pierre Daloze; Huifang Chen
Journal:  Transplantation       Date:  2014-08-15       Impact factor: 4.939

Review 9.  CD40L and Its Receptors in Atherothrombosis-An Update.

Authors:  Nathaly Anto Michel; Andreas Zirlik; Dennis Wolf
Journal:  Front Cardiovasc Med       Date:  2017-06-20

10.  Platelet CD40 ligand and bleeding during P2Y12 inhibitor treatment in acute coronary syndrome.

Authors:  Charlotte Grosdidier; Kelly D Blanz; Pierre Deharo; Denis Bernot; Marjorie Poggi; Delphine Bastelica; Dennis Wolf; Daniel Duerschmied; Michel Grino; Thomas Cuisset; Marie-Christine Alessi; Matthias Canault
Journal:  Res Pract Thromb Haemost       Date:  2019-07-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.